AMRX Amneal Pharmaceuticals, Inc.

$16.20 -0.52%

Healthcare · Pharmaceutical Preparations

Amneal Pharmaceuticals, Inc. (AMRX) is a healthcare company in the Pharmaceutical Preparations industry, with a market capitalization of $5.2 billion. Shares last traded at $16.20, near their 52-week high. Over the past year the stock is up 105.3%. AMRX trades at a price-to-earnings ratio of 71.75, above the Pharmaceutical Preparations median of 16.82. Net profit margin is 2.4%, above the peer median of -0.1%. Revenue grew 8.0% year over year.

Market Cap

$5.2B

Shares Out

319.0M

EPS (TTM)

$0.45

P/E Ratio

36.01

P/S Ratio

1.71

P/B Ratio

—

Dividend / Share

—

Dividend Yield

—

52-Week High

$16.70

52-Week Low

$7.67

Volume

68,367

Avg Vol (3m)

110,188.175

Performance

-0.77%

+37.21%

+31.37%

+33.26%

YTD

+28.05%

+105.26%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

77.81

SMA (50)

$13.36

SMA (200)

$12.39

Price vs SMA50

+21.34%

Price vs SMA200

+30.75%

ATR (14)

$0.83

Financials

Revenue

$3.0B

Net Income

$72M

Gross Margin

36.9%

Operating Margin

13.1%

Net Margin

2.4%

Return on Equity

-158.7%

Return on Assets

2.0%

Current Ratio

2.47

Debt / Equity

-56.63

Revenue Growth (YoY)

+8.0%

Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.

Recent earnings

Period	EPS (diluted)	Reported
Q1 2026	$0.19	2026-05-07
FY 2025	$0.22	2026-02-27
Q3 2025	$0.11	2025-11-06
Q2 2025	$0.11	2025-08-07
Q1 2026	$0.04	2026-05-07
FY 2025	$-0.38	2026-02-27

Full earnings history →

Pharmaceutical Preparations peers

AMRX vs 14 industry peers (Pharmaceutical Preparations), by market cap.

P/E vs peers

71.75 / 16.82 med

+327% premium

P/S vs peers

1.71 / 3.54 med

-52% discount

Net margin vs peers

2.4% / -0.1% med

above median

1–14 of 14


LLY	Lilly (Eli)	$1.04T	50.16	15.88	31.7%	-1.17%
JNJ	Johnson & Johnson	$549.8B	20.51	5.84	28.5%	-2.42%
ONC	Beone Medicines Ltd.	$390.6B	1361.26	73.10	5.4%	+2.83%
ABBV	AbbVie	$382.5B	90.51	6.25	6.9%	-2.16%
MRK	Merck	$281.6B	15.43	4.33	28.1%	-1.30%
ABT	Abbott Laboratories	$154.3B	23.65	3.48	14.7%	+0.09%
PFE	Pfizer	$143.7B	18.50	2.30	12.4%	-2.89%
VRTX	Vertex Pharmaceuticals	$114.6B	28.99	9.55	32.9%	-1.63%
BMY	Bristol Myers Squibb	$110.3B	15.63	2.29	14.6%	-2.35%
REGN	Regeneron Pharmaceuticals	$63.4B	14.08	4.42	31.4%	+0.38%
ALNY	Alnylam Pharmaceuticals	$36.9B	117.57	9.93	8.4%	-1.66%
TEVA	Teva Pharmaceutical Industries Ltd	$36.6B	25.98	2.12	8.2%	-3.33%
ZTS	Zoetis	$33.1B	12.37	3.49	28.2%	+2.09%
RPRX	Royalty Pharma Plc	$23.1B	30.02	9.73	32.4%	-1.30%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.